457 results on '"Steinhilber D"'
Search Results
2. Role of Lipoxygenases in Pathogenesis of Cancer
3. In vitro Cytostatic Effect on Tumor Cells by Carborane-based Dual Cyclooxygenase-2 and 5-Lipoxygenase Inhibitors
4. Synthesis and In Vitro Biological Evaluation of p-Carborane-based Di-tert-butylphenol Analogs
5. Carborane-based Tebufelone Analogs and their Biological Evaluation In Vitro
6. P038 Targeting the hepcidin-ferroportin axis with Nrf2 agonists to treat iron deficiency anaemia in Inflammatory Bowel Disease
7. Studies on Expression and Regulation of 5-Lipoxygenase in Human B Lymphocytes
8. Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening
9. Heterodimer formation with retinoic acid receptor RXRa modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARg
10. Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations
11. l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC are Potent Activators of PPARg
12. Design, Synthesis, and Structure - Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
13. First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters
14. Exploring CYP2J2: Lipid mediators, inhibitors and therapeutic implications
15. Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor
16. 2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52) – a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo
17. A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm
18. pH-Dependent regulation of leukocyte 5-lipoxygenase activity in inflammatory exudates by albumin
19. A test system for leukotriene synthesis inhibitors based on the in-vitro differentiation of the human leukemic cell lines HL-60 and Mono Mac 6
20. Beyond leukotriene formation
21. miR‐574‐5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES‐1 induction
22. Structure optimization of a new class of PPARg antagonists
23. Elucidation of chemical modifier reactivity towards peptides and proteins and the analysis of specific fragmentation by matrix‐assisted laser desorption/ionization collision‐induced dissociation tandem mass spectrometry
24. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products
25. 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities
26. 5-Lipoxygenase contributes to PPARγ activation in macrophages in response to apoptotic cells
27. Drug-Mediated Intracellular Donation of Nitric Oxide Potently Inhibits 5-Lipoxygenase
28. Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-v-Lactamases
29. Sphingosine‐1‐phosphate (S1P) induces potent anti‐inflammatory effects in vitro and in vivo by S1P receptor 4‐mediated suppression of 5‐lipoxygenase activity
30. Carborane‐Based Analogues of 5‐Lipoxygenase Inhibitors Co‐inhibit Heat Shock Protein 90 in HCT116 Cells
31. TGFv/SMAD signalling modulates MLL and MLL-AF4 mediated 5-lipoxygenase promoter activation
32. CarbORev‐5901: The First Carborane‐Based Inhibitor of the 5‐Lipoxygenase Pathway
33. PhAST: pharmacophore alignment search tool
34. Epigenetic Control of Microsomal Prostaglandin E Synthase-1 by HDAC Mediated Recruitment of p300
35. Thermodynamic properties of leukotriene A4 hydrolase inhibitors
36. Development of novel aminothiazole-comprising 5-LO inhibitors
37. Identification and Characterization of a New Protein Isoform of Human 5-Lipoxygenase
38. Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors
39. PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells
40. Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma
41. Three-dimensional structure of human 5-LOX in solution: new insights from SAXS analysis
42. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells
43. Apo structure of human Leukotriene A4 hydrolase
44. Design and synthesis of fused soluble epoxide hydrolase/peroxisome proliferator-activated receptor modulators
45. 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity
46. Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wildtype MLL
47. Die Rolle des Vitamin D Rezeptors bei der Butyrat-induzierten TGF-β1 Signalvermittlung in Caco-2 Zellen
48. The association between vitamin D and the arachidonate 5-lipoxygenase (ALOX-5) gene polymorphism in type 2 diabetes
49. Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL
50. 35 - Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.